Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • GLP-1s for Medicare
  • Drug Control Strategy
  • Misoprostol
  • AI Deepfakes
  • Fruit-Flavored Vapes

WHAT'S NEW

  • GLP-1s for Medicare
  • Drug Control Strategy
  • Misoprostol
  • AI Deepfakes
  • Fruit-Flavored Vapes

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, May 25 2023

Full Issue

DEA Failed To Limit Wholesale Opioid Distributor, Worsening Crisis: Report

News reports say failures of the Drug Enforcement Administration allowed one of the country's largest drug distributors, Morris & Dickson Co., to contribute to the opioid crisis even after a judge recommended it should lose its license. Other news relating to fentanyl is also reported.

AP: DEA's Failure To Punish Distributor Blamed In Opioid Crisis Raises Revolving Door Questions 

The U.S. Drug Enforcement Administration has allowed one of the nation’s largest wholesale drug distributors to keep shipping highly addictive painkillers for nearly four years after a judge recommended it be stripped of its license for its “cavalier disregard” of thousands of suspicious orders fueling the opioid crisis. The DEA did not respond to repeated questions from The Associated Press about its handling of the case against Morris & Dickson Co. or the involvement of a high-profile consultant the company had hired to stave off punishment and who is now DEA Administrator Anne Milgram’s top deputy. (Mustian and Goodman, 5/25)

Also —

Axios: GOP Fentanyl Plan Exposes Fault Lines Over Policing In Drug Policy

House Republicans' first major attempt to address the opioid crisis since taking power is resurfacing a long-running debate over the role of law enforcement in drug policy. The GOP-sponsored HALT Fentanyl Act is up for a House vote on Thursday, marking the 117th Congress' first substantive response to the epidemic. (Moreno, 5/25)

Axios: San Francisco To Launch Pilot Program To Address Fentanyl Crisis

San Francisco's emergency management department announced Tuesday it would launch a pilot program to address "when someone is so far under the influence of drugs that they may pose a danger to themselves or others," The San Francisco Chronicle reports. San Francisco is amid a deadly drug overdose epidemic, primarily driven by the opioid fentanyl. (Dickey, 5/24)

Axios: What To Know About The Fentanyl Crisis

Addressing the fentanyl crisis has become a priority in an often-deadlocked federal government with the Biden administration calling on Congress to pass a bill aimed at tackling fentanyl trafficking in the U.S. The overdose death rate involving the synthetic opioid fentanyl in the U.S. nearly quadrupled between 2016 and 2021, according to the Centers for Disease Control and Prevention. (McBournie, 5/25)

Las Vegas Review-Journal: Hillary Clinton Talks Naloxone In Las Vegas 

Robert Banghart’s life was saved by naloxone twice in one evening when he overdosed from heroin. Banghart, a 47-year-old Las Vegas resident, was living under a bridge at the time when he took his usual dose of heroin and overdosed. Luckily the people he was with had naloxone, an opioid overdose reversal drug that a recovery foundation had provided. After he woke up from the hospital, he left, only to overdose again hours later. (Hill, 5/24)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 6
  • Tuesday, May 5
  • Monday, May 4
  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF